Memantine Hydrochloride 19982-08-2: A Comprehensive Overview for Pharmaceutical Applications
Explore the therapeutic potential and pharmaceutical applications of Memantine Hydrochloride, a key NMDA receptor antagonist.
Get a Quote & SampleProduct Core Value
Memantine Hydrochloride
Memantine Hydrochloride (CAS 19982-08-2) is a vital pharmaceutical intermediate primarily used in the treatment of moderate to severe Alzheimer's disease. It functions as an NMDA receptor antagonist, offering neuroprotection by modulating glutamate activity in the brain. This drug represents a significant advancement in managing cognitive decline associated with neurodegenerative disorders.
- This API raw material is crucial for developing treatments for Alzheimer's disease, offering hope for improved cognitive function.
- Understanding the uses of Memantine Hydrochloride is key for pharmaceutical researchers and developers in the cognitive health sector.
- Sourcing high-quality pharmaceutical intermediates like Memantine Hydrochloride is essential for ensuring the efficacy and safety of final drug products.
- The market for neuroprotective drugs is growing, with Memantine Hydrochloride playing a significant role in this expanding field.
Key Advantages
Neuroprotective Mechanism
Memantine Hydrochloride functions as an NMDA receptor antagonist, which helps protect nerve cells from excessive glutamate stimulation, a factor implicated in Alzheimer's disease pathology. This neuroprotective property is a cornerstone of its therapeutic value.
Therapeutic Efficacy for Dementia
Used to treat moderate-to-severe Alzheimer's disease, this compound offers symptomatic relief and can improve cognitive function, mood, and behavior in patients. Its role in dementia care is well-established.
Quality Assurance
Manufactured under strict quality control standards, including GMP, USP, and ISO 9001, ensuring high purity and reliability for pharmaceutical applications, which is critical when buy pharmaceutical intermediates online.
Key Applications
Alzheimer's Disease Treatment
The primary application of Memantine Hydrochloride is in the treatment of moderate to severe Alzheimer's disease, offering a therapeutic option for patients experiencing cognitive decline.
Neurodegenerative Disorder Research
Its mechanism of action makes it a subject of research for other neurodegenerative conditions, exploring its potential in broader neurological health applications.
Pharmaceutical Intermediate Supply
As a key API raw material, it is supplied to pharmaceutical manufacturers for the synthesis of final dosage forms, supporting the global supply chain for dementia medications.
Cognitive Health Support
Beyond Alzheimer's, it is being investigated for its potential benefits in supporting general cognitive health and addressing age-related cognitive decline.